Article Information
History
- August 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Sofia A Omaria,*,
- Dominic P Geraghtya,1,
- Alhossain A Khalafallaha,b,2,
- Pooja Venkatc,
- Yvette M Shegoga,
- Scott J Raggd,
- Charles E. de Bockc and
- Murray J Adamsa,3
- aSchool of Health Sciences, University of Tasmania. Locked Bag 1322, Launceston 7250, Tasmania, Australia
- bLaunceston General Hospital, Charles Street, Launceston 7250, Tasmania, Australia
- cChildren’s Cancer Institute, School of Women’s and Children’s Health, Lowy Cancer Centre, University of New South Wales (UNSW), Sydney, NSW, Australia
- dPathology Department, Royal Hobart Hospital, 48 Liverpool Street, Hobart 7000, Tasmania, Australia
- ↵*Corresponding Author: Dr. Sofia A Omari
, Children’s Cancer Institute, School of Women’s and Children’s Health, Lowy Cancer Centre, University of New South Wales (UNSW), Sydney, NSW, Australia. Email: somari{at}ccia.org.au
Posted August 08, 2021.
Optimized Flow Cytometric Detection of Transient Receptor Potential Vanilloid-1 (TRPV1) in Human Hematological Malignancies
